ChemoCentryx Inc (OQ:CCXI)

Oct 20, 2022 09:05 am ET
AMGEN SUCCESSFULLY COMPLETES ACQUISITION OF CHEMOCENTRYX
TAVNEOS® (avacopan), a First-in-Class Medicine for Patients With Severe Active ANCA-Associated Vasculitis, Added to Inflammation Portfolio
Oct 17, 2022 08:30 am ET
ChemoCentryx Announces Presentations at the 2022 American Society of Nephrology and American College of Rheumatology Annual Meetings
ChemoCentryx, Inc., (Nasdaq: CCXI), today announced planned presentations covering TAVNEOS® (avacopan), an orally administered selective complement 5a receptor (C5aR) inhibitor, at the American Society of Nephrology (ASN) Kidney Week 2022 and...
Oct 05, 2022 08:30 am ET
ChemoCentryx Announces Upcoming Presentations for Orally Administered PD-L1 Inhibitor, CCX559, at the 2022 Society for Immunotherapy of Cancer (SITC) Annual Meeting
ChemoCentryx, Inc., (Nasdaq: CCXI), today announced two upcoming poster presentations for CCX559, the Company’s investigational, highly potent, orally administered PD-L1 checkpoint inhibitor, at the Society for Immunotherapy of Cancer (SITC) 37th...
Sep 14, 2022 10:10 am ET
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates CYBE, CCXI, AVLR
NEW YORK, Sept. 14, 2022 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Sep 13, 2022 11:38 am ET
INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates ChemoCentryx, Inc.’s Directors and Officers for Breach of Fiduciary Duties – CCXI
Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating whether certain directors and officers of ChemoCentryx, Inc. (“ChemoCentryx”) (NASDAQ: CCXI) breached their fiduciary duties to ChemoCentryx and its shareholders.
Aug 31, 2022 01:16 pm ET
SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates CCXI, HIL, CSVI, AERI
NEW YORK, Aug. 31, 2022 /PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Aug 30, 2022 07:06 pm ET
INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates ChemoCentryx, Inc.’s Directors and Officers for Breach of Fiduciary Duties – CCXI
Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating whether certain directors and officers of ChemoCentryx, Inc. (“ChemoCentryx”) (NASDAQ: CCXI) breached their fiduciary duties to ChemoCentryx and its shareholders.
Aug 25, 2022 11:26 am ET
SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates ONEM, CCXI, AERI, SFT
NEW YORK, Aug. 25, 2022 /PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Aug 24, 2022 08:30 am ET
ChemoCentryx Announces TAVNEOS® (avacopan) Presentations at Upcoming Medical Conferences
ChemoCentryx, Inc., (Nasdaq: CCXI), today announced planned poster presentations at three upcoming medical conferences taking place in August and September, which highlight TAVNEOS® (avacopan), an orally administered selective complement 5a...
Aug 19, 2022 08:42 am ET
SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates MVBF, HIL, CCXI, IRBT
Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: MVB Financial Corp. (NASDAQ: MVBF)’s...
Aug 10, 2022 07:54 am ET
SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates AAWW, CCXI, IRBT
NEW YORK, Aug. 10, 2022 /PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Aug 09, 2022 01:58 pm ET
Shareholder Alert - The M&A Class Action Firm Announces the Investigation of ChemoCentryx, Inc. - CCXI
NEW YORK, Aug. 9, 2022 /PRNewswire/ -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating ChemoCentryx, Inc. (CCXI), relating to its proposed acquisition by Amgen Inc. Under the terms of the agreement, CCXI shareholders are expected to receive $52.00 in cash per share they own. Click here for more information: https://www.monte
Aug 09, 2022 08:30 am ET
ChemoCentryx Cancels Second Quarter 2022 Financial Results Conference Call
ChemoCentryx, Inc., (Nasdaq: CCXI), today announced the cancellation of its second quarter 2022 financial results conference call scheduled for Tuesday, August 9, 2022, at 5:00 p.m. ET. The call is being cancelled due to the August 4, 2022,...
Aug 08, 2022 12:00 am ET
SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates AAWW, CCXI, IRBT
Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Atlas Air Worldwide Holdings, Inc....
Aug 07, 2022 08:05 pm ET
CHEMOCENTRYX, INC. ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of CCXI and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the officers or directors of ChemoCentryx, Inc. (NASDAQ: CCXI) (“ChemoCentryx”) breached their fiduciary duties or violated...
Aug 05, 2022 12:48 pm ET
SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates AAWW, CCXI, IRBT, RADA
NEW YORK, Aug. 5, 2022 /PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Aug 04, 2022 04:45 pm ET
SHAREHOLDER ALERT: Weiss Law Investigates ChemoCentryx, Inc
NEW YORK, Aug. 4, 2022 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of ChemoCentryx, Inc. ("ChemoCentryx" or the "Company") (NASDAQ: CCXI), in connection with the proposed acquisition of the Company by Amgen Inc. (NASDAQ: AMGN).Under the terms of the merger agreement, the Company's shareholders will receive $52.00 in cash for each share of ChemoCentryx common stock owned. The transaction is valued at approximately $3.7 billion.
Aug 04, 2022 04:19 pm ET
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of ChemoCentryx, Inc. (Nasdaq – CCXI)
Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of ChemoCentryx, Inc. (“ChemoCentryx” or the “Company”) (Nasdaq – CCXI) for possible breaches of fiduciary duty and other violations of...
Aug 04, 2022 11:18 am ET
Shareholder Alert: Ademi LLP investigates whether ChemoCentryx, Inc. has obtained a Fair Price in its transaction with Amgen
MILWAUKEE, Aug. 4, 2022 /PRNewswire/ -- Ademi LLP is investigating ChemoCentryx (NASDAQ: CCXI) for possible breaches of fiduciary duty and other violations of law in its transaction with Amgen. 
Aug 04, 2022 09:39 am ET
Thinking about buying stock in ChemoCentryx, Invivo Therapeutics, Greenlight Biosciences, Missfresh, or NanoViricides?
NEW YORK, Aug. 4, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CCXI, NVIV, GRNA, MF, and NNVC.
Aug 04, 2022 09:05 am ET
CCXI Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of ChemoCentryx, Inc. Is Fair to Shareholders
Halper Sadeh LLP, an investor rights law firm, is investigating whether the sale of ChemoCentryx, Inc. (NASDAQ: CCXI) to Amgen Inc. for $52.00 per share in cash is fair to ChemoCentryx shareholders.
Aug 04, 2022 08:00 am ET
AMGEN TO ACQUIRE CHEMOCENTRYX FOR $4 BILLION IN CASH
Acquisition Includes TAVNEOS® (avacopan), a First-in-Class Medicine for Patients With Serious Autoimmune Disease 
Aug 02, 2022 04:05 pm ET
ChemoCentryx to Hold Second Quarter 2022 Financial Results Conference Call on Tuesday, August 9, 2022
ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the Company's second quarter 2022 financial results will be released after market close on Tuesday, August 9, 2022. ChemoCentryx executive management will host a conference call and webcast...
Jul 05, 2022 08:30 am ET
ChemoCentryx Announces Appointment of Jennifer L. Herron to Board as Independent Director
ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that Jennifer L. Herron has been appointed to the Board as an independent director, effective June 28, 2022. With this appointment, the Board increases the number of directors constituting the...
Jun 06, 2022 08:30 am ET
ChemoCentryx Reports Safety Results Available from Ongoing Phase I Trial of Orally Administered PD-L1 Inhibitor, CCX559, at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
ChemoCentryx, Inc., (Nasdaq: CCXI), today announced the presentation of safety results from the ongoing Phase I clinical study of CCX559, the Company’s highly potent, orally administered PD-L1 checkpoint inhibitor, in patients with advanced solid...
May 31, 2022 04:05 pm ET
ChemoCentryx Announces Abstracts at June Rheumatology, Oncology and Nephrology Conferences
ChemoCentryx, Inc., (Nasdaq: CCXI), today announced upcoming abstract presentations at three key medical conferences taking place in June, which highlight TAVNEOS® (avacopan), an orally administered selective complement 5a receptor (C5aR)...
May 31, 2022 08:30 am ET
ChemoCentryx Announces Changes to its Board of Directors
ChemoCentryx, Inc., (Nasdaq: CCXI), today announced changes to the composition of its Board of Directors. David E. Wheadon, M.D., has been elected to the Board as an independent director, and Henry A. McKinnell, Jr., Ph.D., is retiring from the...
May 18, 2022 08:30 am ET
ChemoCentryx Announces Presentation at the Society for Investigative Dermatology Meeting Highlighting the Role of Tunnels in Driving Ongoing Disease in Hidradenitis Suppurativa
ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that a poster will be presented at the Society for Investigative Dermatology (SID) 2022 Annual Meeting, to be held May 18-21, 2022 in Portland, Oregon, that highlights unique immunological...
May 16, 2022 08:30 am ET
ChemoCentryx to Present at the H.C. Wainwright Global Investment Conference
ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that Thomas J. Schall, Ph.D., President and Chief Executive Officer, will present at the H.C. Wainwright Global Investment Conference on Tuesday, May 24, 2022 at 12:30 p.m. ET. The conference will...
May 11, 2022 08:30 am ET
ChemoCentryx Announces Upcoming Conference Abstracts Focused on TAVNEOS® (avacopan) and the Burden of Systemic Glucocorticoid Use in ANCA-Associated Vasculitis
ChemoCentryx, Inc., (Nasdaq: CCXI), today announced upcoming presentations at three key medical conferences that will highlight findings from the pivotal Phase III ADVOCATE trial that supported the approval of TAVNEOS® (avacopan), an orally...
May 06, 2022 08:36 am ET
Thinking about buying stock in Draftkings, ChemoCentryx, Opendoor Technologies, 1life Healthcare, or Enservco Corp?
NEW YORK, May 6, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for DKNG, CCXI, OPEN, ONEM, and ENSV.
May 05, 2022 04:05 pm ET
ChemoCentryx Reports First Quarter 2022 Financial Results and Recent Highlights
ChemoCentryx, Inc., (Nasdaq: CCXI), today announced financial results for the first quarter ended March 31, 2022 and provided an overview of recent corporate highlights. “Strong performance was evident in the first quarter,” said Thomas J. Schall,...
Apr 28, 2022 08:30 am ET
ChemoCentryx to Hold First Quarter 2022 Financial Results Conference Call on Thursday, May 5, 2022
ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the Company's first quarter 2022 financial results will be released after market close on Thursday, May 5, 2022. ChemoCentryx executive management will host a conference call and webcast...
Apr 13, 2022 08:30 am ET
ChemoCentryx Reports Pharmacokinetic and Pharmacodynamic Results from Ongoing Phase I Trial of Orally Administered PD-L1 Inhibitor, CCX559, at American Association for Cancer Research (AACR) Annual Me
ChemoCentryx, Inc., (Nasdaq: CCXI), today announced the presentation of preclinical data and initial pharmacokinetic (PK) and pharmacodynamic (PD) data from the ongoing Phase I clinical study of CCX559 during a poster session at the American...
Mar 18, 2022 09:04 pm ET
CHEMOCENTRYX INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of ChemoCentryx, Inc. - CCXI
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into ChemoCentryx, Inc. (NasdaqGS: CCXI).
Mar 04, 2022 10:00 pm ET
CHEMOCENTRYX INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of ChemoCentryx, Inc. - CCXI
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into ChemoCentryx, Inc. (NasdaqGS: CCXI).
Mar 04, 2022 09:00 pm ET
Bragar Eagel & Squire is Investigating Certain Officers and Directors of Ardelyx, BioMarin, Chegg, and ChemoCentryx on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating certain officers and directors Ardelyx, Inc. (NASDAQ: ARDX), BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN), Chegg, Inc. (NYSE: CHGG), and...
Mar 03, 2022 11:13 am ET
INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in ChemoCentryx, Inc. with Losses of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in ChemoCentryx, Inc. (“ChemoCentryx” or “the Company”) (NASDAQ:
Mar 02, 2022 08:57 pm ET
(CCXI Alert) Should Management be Held Accountable for ChemoCentryx Investors Losses? Contact Johnson Fistel
Johnson Fistel, LLP is investigating potential claims on behalf of ChemoCentryx, Inc. ("ChemoCentryx" or "the Company") (NASDAQ: CCXI) against certain of its officers and directors. Last year a class action suit was filed against ChemoCentryx. The...
Mar 02, 2022 06:30 pm ET
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in ChemoCentryx, Inc. with Losses of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in ChemoCentryx, Inc. (“ChemoCentryx” or “the Company”) (NASDAQ:
Mar 01, 2022 04:05 pm ET
ChemoCentryx Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Highlights
ChemoCentryx, Inc., (Nasdaq: CCXI), today announced financial results for the fourth quarter and full year ended December 31, 2021 and provided an overview of recent corporate highlights. “In 2021 we achieved our long-standing goal of becoming an...
Feb 23, 2022 08:30 am ET
ChemoCentryx to Hold Fourth Quarter and Full Year 2021 Financial Results Conference Call on Tuesday, March 1, 2022
ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the Company's fourth quarter and full year 2021 financial results will be released after market close on Tuesday, March 1, 2022. ChemoCentryx executive management will host a conference call...
Feb 18, 2022 09:50 pm ET
CHEMOCENTRYX INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of ChemoCentryx, Inc. - CCXI
NEW ORLEANS, Feb. 18, 2022 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced an investigation into ChemoCentryx, Inc. (NasdaqGS: CCXI).
Feb 09, 2022 08:30 am ET
ChemoCentryx to Participate in the 11th Annual SVB Leerink Global Healthcare Conference
ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that Thomas J. Schall, Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the 11th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 16th at...
Jan 27, 2022 12:49 pm ET
SHAREHOLDER ALERT: Robbins LLP Investigates ChemoCentryx, Inc. (CCXI) on Behalf of Shareholders
Shareholder rights law firm Robbins LLP is investigating ChemoCentryx, Inc. (NASDAQ: CCXI) to determine whether certain ChemoCentryx officers and directors violated securities laws and breached fiduciary duties to shareholders. ChemoCentryx is a biopharmaceutical company that develops and commercializes new medications targeting infla
Jan 19, 2022 08:30 am ET
ChemoCentryx Announces EU Approval of TAVNEOS® (avacopan) for the Treatment of ANCA-Associated Vasculitis
ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that TAVNEOS® (avacopan) has been approved within the European Union in combination with a rituximab or cyclophosphamide regimen for the treatment of adult patients with severe, active...
Jan 04, 2022 08:30 am ET
ChemoCentryx to Present at Two Upcoming Investor Conferences
ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that Thomas J. Schall, Ph.D., President and Chief Executive Officer, will present at two upcoming investor conferences: 40th Annual J.P. Morgan Healthcare ConferenceWednesday, January 12 at 4:30...
Nov 12, 2021 08:30 am ET
Positive Recommendation for Use of TAVNEOS™ (avacopan) in ANCA Vasculitis Adopted by European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP)
ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending marketing authorization for the Company’s TAVNEOS...
Nov 10, 2021 08:00 am ET
ChemoCentryx to Participate in Two Upcoming Investor Conferences
ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that Thomas J. Schall, Ph.D., President and Chief Executive Officer, will participate in two upcoming investor conferences: Stifel 2021 Virtual Healthcare ConferenceFireside Chat Wednesday,...
Nov 09, 2021 04:05 pm ET
ChemoCentryx Reports Third Quarter 2021 Financial Results and Recent Highlights
ChemoCentryx, Inc., (Nasdaq: CCXI), today announced financial results for the third quarter ended September 30, 2021 and provided an overview of recent corporate highlights. “TAVNEOS is approved and now launched in the U.S.,” said Thomas J....
Nov 04, 2021 08:30 am ET
Abstracts at the Annual Meetings of the American Society of Nephrology and American College of Rheumatology Highlight Potential Value of TAVNEOS™ (avacopan)
ChemoCentryx, Inc., (Nasdaq: CCXI), today announced the abstracts accepted for presentation and publication as part of the annual meetings of the American Society of Nephrology (ASN) Kidney Week 2021 and American College of Rheumatology (ACR)...
Nov 02, 2021 08:30 am ET
ChemoCentryx to Hold Third Quarter 2021 Financial Results Conference Call on Tuesday, November 9, 2021
ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the Company's third quarter 2021 financial results will be released after market close on Tuesday, November 9, 2021. ChemoCentryx executive management will host a conference call and webcast...
Oct 11, 2021 10:55 am ET
Thinking about trading options or stock in Occidental Petroleum, ChemoCentryx, Tata Motors, Lowe's, or Daqo New Energy?
NEW YORK, Oct. 11, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for OXY, CCXI, TTM, LOW, and DQ.
Oct 11, 2021 08:30 am ET
ChemoCentryx Appoints Rita I. Jain, M.D. as Executive Vice President, Chief Medical Officer
ChemoCentryx, Inc., (Nasdaq: CCXI), today announced the appointment of Rita I. Jain, M.D., as Executive Vice President, Chief Medical Officer. In this role, she will oversee development activities including clinical development, development...
Oct 08, 2021 08:30 am ET
Thinking about buying stock in ChemoCentryx, Sundial Growers, Momentive Global, Vaxart, or Biomerica?
NEW YORK, Oct. 8, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CCXI, SNDL, MNTV, VXRT, and BMRA.
Oct 08, 2021 07:00 am ET
ChemoCentryx Announces FDA Approval of TAVNEOS™ (avacopan) in ANCA-Associated Vasculitis
ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the U.S. Food and Drug Administration (FDA) has approved TAVNEOS (avacopan), an orally administered selective complement 5a receptor inhibitor, as an adjunctive treatment of adult patients...
Sep 27, 2021 08:30 am ET
ChemoCentryx Announces Approval in Japan of TAVNEOS™ (Avacopan) for the Treatment of ANCA-Associated Vasculitis
ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that Kissei Pharmaceutical Co., Ltd. has received approval from the Japanese Ministry of Health, Labor, and Welfare (MHLW) to market TAVNEOS™ (avacopan), an orally administered selective...
Sep 02, 2021 08:30 am ET
ChemoCentryx to Participate in Two Upcoming Investor Conferences
ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that Thomas J. Schall, Ph.D., President and Chief Executive Officer, will participate in two upcoming investor conferences: 2021 Virtual Wells Fargo Healthcare ConferenceFireside Chat...
Aug 09, 2021 04:05 pm ET
ChemoCentryx Reports Second Quarter 2021 Financial Results and Recent Highlights
ChemoCentryx, Inc., (Nasdaq: CCXI), today announced financial results for the second quarter ended June 30, 2021 and provided an overview of recent corporate highlights. "We appreciate the recent opportunity to provide the U.S. FDA with...
Aug 06, 2021 01:54 pm ET
Lifshitz Law Firm, P.C. Announces Investigations of 3D Systems Corp. (NYSE: DDD), Acadia Pharmaceuticals, Inc. (NasdaqGS: ACAD), ChemoCentryx, Inc. (NasdaqGS: CCXI), and Peloton Interactive, Inc (Nasd
3D Systems Corp. (NYSE: DDD) Lifshitz Law Firm, P.C. announces that a class action complaint was filed against DDD alleging that DDD made false and/or misleading statements and/or failed to disclose that: (1) DDD lacked proper internal controls...
Aug 04, 2021 08:30 am ET
ChemoCentryx to Participate in the Canaccord Genuity 41st Annual Growth Conference
ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that Thomas J. Schall, Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the Canaccord Genuity 41st Annual Growth Conference on Wednesday, August 11 at 5:00 p.m....
Aug 02, 2021 08:30 am ET
ChemoCentryx to Hold Second Quarter 2021 Financial Results Conference Call on Monday, August 9, 2021
ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the Company's second quarter 2021 financial results will be released after market close on Monday, August 9, 2021. ChemoCentryx executive management will host a conference call and webcast...
Jul 07, 2021 11:14 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ChemoCentryx, Inc. - CCXI
Pomerantz LLP is investigating claims on behalf of investors of  ChemoCentryx, Inc. (“ChemoCentryx” or the “Company”) (NASDAQ: CCXI). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980....
Jul 07, 2021 10:45 am ET
Thinking about buying stock in Ashford Hospitality Trust, Bridgeline Digital, Inuvo, Newegg Commerce, or ChemoCentryx?
NEW YORK, July 7, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AHT, BLIN, INUV, NEGG, and CCXI.
Jul 07, 2021 08:21 am ET
(CCXI Long-Term Investor Alert: Did You Acquire ChemoCentryx Before November 26, 2019? Should Management be Held Accountable for Investors Losses?
SAN DIEGO, July 7, 2021 /PRNewswire/ -- Johnson Fistel, LLP is investigating potential claims on behalf of ChemoCentryx Inc. ("ChemoCentryx" or the "Company") (NASDAQ: CCXI) against certain of its current and former officers and directors. 
Jul 06, 2021 10:55 am ET
Thinking about buying stock in Clover Health, Transocean, ChemoCentryx, BioHiTech Global, or Welbilt?
NEW YORK, July 6, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CLOV, RIG, CCXI, BHTG, and WBT.
Jul 06, 2021 10:00 am ET
CCXI Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds ChemoCentryx, Inc. Investors of Class Action and Lead Plaintiff Deadline: July 6, 2021
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against ChemoCentryx, Inc. ("ChemoCentryx" or "the Company") (NASDAQ: CCXI) and certain of its officers, on behalf of...
Jul 06, 2021 08:30 am ET
ChemoCentryx Announces Filing of Amendment to NDA Submission and Extension of the PDUFA Review Period for Avacopan in the Treatment of ANCA-Associated Vasculitis
ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that, following consultations with the U.S. Food and Drug Administration (FDA), it filed an amendment to its New Drug Application (NDA) for avacopan for the treatment of Anti-neutrophil...
Jul 05, 2021 11:36 pm ET
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS ARRY, CCXI, PCT, WISH INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: ChemoCentryx, Inc. (CCXI)Class Period: 11/26/2019...
Jul 05, 2021 11:09 pm ET
CHEMOCENTRYX 24 HOUR DEADLINE ALERT: FORMER LOUISIANA ATTORNEY GENERAL AND KAHN SWICK & FOTI, LLC REMIND INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Deadline in Class Action Lawsuits Against ChemoC
NEW ORLEANS, July 5, 2021 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have only until July 6, 2021 to file lead plaintiff applications in securities class action lawsuits against ChemoCentryx, Inc. (NasdaqGS: CCXI), if they purchased the Company's shares between November 26, 2019 and May 6, 2021, inclusive (the "Class Period").  These actions are pending in the United States District Court for the Northern District of California.
Jul 05, 2021 10:10 am ET
Kessler Topaz Meltzer & Checker, LLP: Final Deadline Reminder for ChemoCentryx, Inc. Investors - CCXI
RADNOR, Pa., July 5, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed against ChemoCentryx, Inc. (NASDAQ: CCXI) ("ChemoCentryx") on behalf of those who purchased or acquired ChemoCentryx common stock between November 26, 2019 and May 6, 2021, inclusive (the "Class Period").
Jul 04, 2021 12:19 pm ET
CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Reminds ChemoCentryx, Inc. Shareholders of Securities Fraud Class Action Lawsuit
The law firm of Kessler Topaz Meltzer & Check, LLP reminds ChemoCentryx, Inc. (NASDAQ: CCXI) (“ChemoCentryx”) investors that a securities fraud class action lawsuit has been filed in the United States District Court for the Northern District of...
Jul 04, 2021 11:15 am ET
FINAL DEADLINE ALERT: ROSEN, A LEADING LAW FIRM, Encourages ChemoCentryx, Inc. Investors with Losses to Secure Counsel Before Important Tuesday Deadline in Securities Class Action – CCXI
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of ChemoCentryx, Inc. (NASDAQ: CCXI) between November 26, 2019 and May 6, 2021, inclusive (the “Class Period”), of the important July 6, 2021 lead...
Jul 03, 2021 03:13 pm ET
CCXI DEADLINE: Kessler Topaz Meltzer & Check, LLP Reminds Investors of ChemoCentryx, Inc. of Deadline in Securities Fraud Class Action Lawsuit
The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed against ChemoCentryx, Inc. (NASDAQ: CCXI) (“ChemoCentryx”) on behalf of those who purchased or acquired ChemoCentryx common stock between November 26, 2019 and May 6, 2021, inclusive (the “Class Period”).
Jul 02, 2021 10:50 pm ET
CHEMOCENTRYX 96 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuits Against ChemoC
Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have only until July 6, 2021 to file lead plaintiff applications in securities class action lawsuits against ChemoCentryx, Inc. (NasdaqGS: CCXI), if they purchased the Company’s shares between November 26, 2019 and May 6, 2021, inclusive (the “Class Period”). These actions are pending in the United States District Court for the Northern District of California.
Jul 02, 2021 10:50 pm ET
SHAREHOLDER ALERT: CLAIMSFILER REMINDS ARRY, CCXI, PCT, WISH INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: ChemoCentryx, Inc. (CCXI)Class Period: 11/26/2019 - 5/6/2021Lead Plaintiff Motion Deadline: July 6,...
Jul 02, 2021 10:00 pm ET
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against ChemoCentryx, Inc. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, announces that a class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of investors that purchased ChemoCentryx, Inc. (NASDAQ: CCXI) securities between November 26, 2019 and May 3, 2021, inclusive (the “Class Period”). Investors have until July 6, 2021 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
Jul 01, 2021 11:05 am ET
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of ChemoCentryx, Inc. (CCXI) Investors
LOS ANGELES, July 1, 2021 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired ChemoCentryx, Inc. ("ChemoCentryx" or the "Company") (NASDAQ: CCXI) common stock between November 26, 2019 and May 6, 2021, inclusive (the "Class Period"). ChemoCentryx investors have until July 6, 2021 to file a lead plaintiff motion.
Jun 30, 2021 10:12 pm ET
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS ARRY, CCXI, PCT, WISH INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: ChemoCentryx, Inc. (CCXI)Class Period: 11/26/2019...
Jun 30, 2021 06:46 pm ET
Deadline Alert: Kessler Topaz Meltzer & Check, LLP Alerts Investors of Lead Plaintiff Deadline in Securities Fraud Class Action Lawsuit Against ChemoCentryx, Inc.
The law firm of Kessler Topaz Meltzer & Check, LLP reminds ChemoCentryx, Inc. (NASDAQ: CCXI) (“ChemoCentryx”) investors that a securities fraud class action lawsuit has been filed in the United States District Court for the Northern District of...
Jun 30, 2021 12:10 pm ET
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against ChemoCentryx, Inc. (CCXI)
The Law Offices of Frank R. Cruz reminds investors of the upcoming July 6, 2021 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased ChemoCentryx, Inc. (“ChemoCentryx” or the “Company”) (NASDAQ:
Jun 30, 2021 11:00 am ET
CCXI Approaching Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds ChemoCentryx, Inc. Investors of Class Action and Lead Plaintiff Deadline: July 6, 2021
Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against ChemoCentryx, Inc. ("ChemoCentryx" or "the Company") (NASDAQ: CCXI) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired ChemoCentryx securities between November 26, 2019 and May 6, 2021, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm’s site:
Jun 29, 2021 11:35 pm ET
CCXI Deadline Alert: Kessler Topaz Meltzer & Check, LLP Reminds Investors or July 6, 2021 Deadline in Securities Fraud Class Action Lawsuit
RADNOR, Pa., June 29, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP reminds ChemoCentryx, Inc. (NASDAQ: CCXI) ("ChemoCentryx") investors that a securities fraud class action lawsuit has been filed on behalf of those who purchased or acquired ChemoCentryx common stock between November 26, 2019 and May 6, 2021, inclusive (the "Class Period").
Jun 29, 2021 11:33 pm ET
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of ARRY, CCXI, PCT and WISH
The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of the following publicly traded companies. ChemoCentryx, Inc. (CCXI)Class Period: September 11, 2020 and May 6, 2021Lead Plaintiff Motion Deadline: July 6,...
Jun 29, 2021 12:30 pm ET
DEADLINE ALERT for CCXI, SKLZ, PCT, ATER: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Jun 28, 2021 10:50 pm ET
SHAREHOLDER ALERT: CLAIMSFILER REMINDS ARRY, CCXI, PCT, WISH INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: ChemoCentryx, Inc. (CCXI)Class Period: 11/26/2019 - 5/6/2021Lead Plaintiff Motion Deadline: July 6,...
Jun 28, 2021 04:16 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ChemoCentryx, Inc. - CCXI
Pomerantz LLP is investigating claims on behalf of investors of  ChemoCentryx, Inc. (“ChemoCentryx” or the “Company”) (NASDAQ: CCXI). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980....
Jun 28, 2021 01:00 pm ET
DEADLINE ALERT for VWAGY, CCIV, CCXI, and SKLZ: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the deadlines listed below to file a lead plaintiff motion....
Jun 28, 2021 09:50 am ET
CCXI 8-DAY DEADLINE ALERT: Hagens Berman Encourages ChemoCentryx (CCXI) Investors with Losses to Contact the Firm Now, Securities Fraud Deadline Approaching
Hagens Berman urges ChemoCentryx, Inc. (NASDAQ: CCXI) investors with significant losses to submit your losses now. A securities fraud class action is pending and certain investors may have valuable claims. Class Period: Nov. 26, 2019 – May 6,...
Jun 28, 2021 09:31 am ET
Thinking about buying stock in Iterum Therapeutics, Kymera Therapeutics, Senseonics, Avrobio, or ChemoCentryx?
NEW YORK, June 28, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ITRM, KYMR, SENS, AVRO, and CCXI.
Jun 28, 2021 08:00 am ET
ChemoCentryx, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm
The Portnoy Law Firm advises investors that a class action lawsuit has been filed on behalf of ChemoCentryx, Inc. (NASDAQ: CCXI) investors that acquired shares between November 26, 2019 and May 3, 2021. Investors have until July 6, 2021 to seek an...
Jun 26, 2021 01:14 pm ET
ROSEN, SKILLED INVESTOR COUNSEL, Encourages ChemoCentryx, Inc. Investors to Secure Counsel Before Important July 6 Deadline in Securities Class Action – CCXI
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of ChemoCentryx, Inc. (NASDAQ: CCXI) between November 26, 2019 and May 6, 2021, inclusive (the “Class Period”), of the important July 6, 2021 lead...
Jun 25, 2021 11:01 pm ET
(CCXI) Deadline Alert: Investors With Losses Over $100,000 Interested in Being a Lead Plaintiff in Securities Fraud Class Action Lawsuit Against ChemoCentryx Inc. – Contact Johnson Fistel
Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of investors of ChemoCentryx Inc. ("ChemoCentryx" or the "Company") (NASDAQ: CCXI). The class action is on behalf of...
Jun 25, 2021 10:50 pm ET
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS ARRY, CCXI, PCT, WISH INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: ChemoCentryx, Inc. (CCXI)Class Period: 11/26/2019...
Jun 25, 2021 11:30 am ET
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against ChemoCentryx, Inc. (CCXI)
BENSALEM, Pa., June 25, 2021 /PRNewswire/ -- Law Offices of Howard G. Smith reminds investors of the upcoming July 6, 2021 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased ChemoCentryx, Inc. ("ChemoCentryx" or the "Company") (NASDAQ: CCXI) common stock between November 26, 2019 and May 6, 2021, inclusive (the "Class Period").
Jun 25, 2021 10:20 am ET
Lead Plaintiff Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed Against ChemoCentryx, Inc.
The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors that a securities fraud class action lawsuit has been filed in the United States District Court for the Northern District of California against ChemoCentryx, Inc. (NASDAQ: CCXI)...
Jun 24, 2021 12:30 pm ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against ChemoCentryx, Inc. (CCXI)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming July 6, 2021 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired ChemoCentryx, Inc. (“ChemoCentryx” or...
Jun 24, 2021 10:00 am ET
VWAGY, CCXI & SKLZ Shareholder Alert: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions and Encourages Investors to Contact the Firm
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaint by visiting the links below or you may...
Jun 23, 2021 10:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against ChemoCentryx, AcelRx, Ocugen, and Tarena and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of ChemoCentryx, Inc. (NASDAQ: CCXI), AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX),...
Jun 23, 2021 10:00 pm ET
SHAREHOLDER ALERT: CLAIMSFILER REMINDS ARRY, CCXI, PCT, WISH INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: ChemoCentryx, Inc. (CCXI)Class Period: 11/26/2019 - 5/6/2021Lead Plaintiff Motion Deadline: July 6,...
Jun 23, 2021 04:15 pm ET
Investor Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against ChemoCentryx, Inc. (CCXI)
RADNOR, Pa., June 23, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP alerts investors that a securities fraud class action lawsuit has been filed against ChemoCentryx, Inc. (NASDAQ: CCXI) ("ChemoCentryx") on behalf of those who purchased or acquired ChemoCentryx common stock between November 26, 2019 and May 6, 2021, inclusive (the "Class Period").
Jun 22, 2021 11:14 pm ET
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of ARRY, CCXI, PCT and WISH
The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of the following publicly traded companies. ChemoCentryx, Inc. (CCXI)Class Period: September 11, 2020 and May 6, 2021Lead Plaintiff Motion Deadline: July 6,...
Jun 22, 2021 06:45 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ChemoCentryx, Inc. - CCXI
NEW YORK, June 22, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  ChemoCentryx, Inc. ("ChemoCentryx" or the "Company") (NASDAQ: CCXI).  Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
Jun 22, 2021 01:46 pm ET
HAGENS BERMAN Encourages ChemoCentryx (CCXI) Investors with Losses to Contact the Firm Before July 6 Deadline in Securities Class Action
Hagens Berman urges ChemoCentryx, Inc. (NASDAQ: CCXI) investors with significant losses to submit your losses now. A securities fraud class action is pending and certain investors may have valuable claims. Class Period: Nov. 26, 2019 – May 6,...
Jun 22, 2021 11:00 am ET
DEADLINE ALERT for CCXI, SKLZ, PCT, ATER: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Jun 21, 2021 10:38 pm ET
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS ARRY, CCXI, PCT, WISH INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: ChemoCentryx, Inc. (CCXI)Class Period: 11/26/2019...
Jun 21, 2021 01:38 pm ET
Shareholder Alert: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of ChemoCentryx, Inc. of Securities Class Action Lawsuit
The law firm of Kessler Topaz Meltzer & Check, LLP reminds ChemoCentryx, Inc. (NASDAQ: CCXI) (“ChemoCentryx”) investors that a securities fraud class action lawsuit has been filed in the United States District Court for the Northern District of...
Jun 21, 2021 12:00 pm ET
DEADLINE ALERT for PINS, VWAGY, CCXI, and SKLZ: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the deadlines listed below to file a lead plaintiff motion....
Jun 20, 2021 01:23 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ChemoCentryx, Inc. - CCXI
Pomerantz LLP is investigating claims on behalf of investors of  ChemoCentryx, Inc. (“ChemoCentryx” or the “Company”) (NASDAQ: CCXI). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980....
Jun 19, 2021 02:30 pm ET
ROSEN, NATIONAL TRIAL LAWYERS, Encourages ChemoCentryx, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important July 6 Deadline in Securities Class Action – CCXI
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of ChemoCentryx, Inc. (NASDAQ: CCXI) between November 26, 2019 and May 6, 2021, inclusive (the “Class Period”), of the important July 6, 2021 lead plaintiff deadline.
Jun 18, 2021 10:50 pm ET
SHAREHOLDER ALERT: CLAIMSFILER REMINDS ARRY, CCXI, PCT, WISH INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: ChemoCentryx, Inc. (CCXI)Class Period: 11/26/2019 - 5/6/2021Lead Plaintiff Motion Deadline: July 6,...
Jun 17, 2021 11:50 am ET
Investor Deadline Alert: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against ChemoCentryx, Inc. (CCXI)
RADNOR, Pa., June 17, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed against ChemoCentryx, Inc. (NASDAQ: CCXI) ("ChemoCentryx") on behalf of those who purchased or acquired ChemoCentryx common stock between November 26, 2019 and May 6, 2021, inclusive (the "Class Period").
Jun 17, 2021 09:06 am ET
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages ChemoCentryx (CCXI) Investors with Losses to Contact the Firm, Application Deadline Approaching in Securities Fraud Action
Hagens Berman urges ChemoCentryx, Inc. (NASDAQ: CCXI) investors with significant losses to submit your losses now. A securities fraud class action is pending and certain investors may have valuable claims. Class Period: Nov. 26, 2019 – May...
Jun 16, 2021 10:32 pm ET
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS ARRY, CCXI, PCT, WISH INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: ChemoCentryx, Inc. (CCXI)Class Period: 11/26/2019...
Jun 16, 2021 10:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Peloton, ChemoCentryx, and AcelRx and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Peloton Interactive, Inc. (NASDAQ: PTON), ChemoCentryx, Inc. (NASDAQ: CCXI), and...
Jun 16, 2021 08:19 pm ET
Kessler Topaz Meltzer & Check, LLP: Securities Fraud Class Action Lawsuit Filed Against ChemoCentryx, Inc.
The law firm of Kessler Topaz Meltzer & Check, LLP reminds ChemoCentryx, Inc. (NASDAQ: CCXI) (“ChemoCentryx”) investors that a securities fraud class action lawsuit has been filed in the United States District Court for the Northern District of...
Jun 16, 2021 05:04 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ChemoCentryx, Inc. - CCXI
NEW YORK, June 16, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  ChemoCentryx, Inc. ("ChemoCentryx" or the "Company") (NASDAQ: CCXI). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
Jun 16, 2021 11:15 am ET
DEADLINE ALERT for PINS, VWAGY, CCXI, and SKLZ: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the deadlines listed below to file a lead plaintiff motion....
Jun 16, 2021 08:30 am ET
ChemoCentryx to Participate in the Raymond James 2021 Human Health Innovations Conference
ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that Thomas J. Schall, Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the Raymond James 2021 Human Health Innovations Conference on Wednesday, June 23 at...
Jun 15, 2021 11:10 pm ET
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of ARRY, CCXI, PCT and WISH
The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of the following publicly traded companies. ChemoCentryx, Inc. (CCXI)Class Period: September 11, 2020 and May 6, 2021Lead Plaintiff Motion Deadline: July 6,...
Jun 15, 2021 05:02 pm ET
ROSEN, A LEADING LAW FIRM, Encourages ChemoCentryx, Inc. Investors With Losses to Secure Counsel Before Important July 6 Deadline in Securities Class Action – CCXI
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of ChemoCentryx, Inc. (NASDAQ: CCXI) between November 26, 2019 and May 6, 2021, inclusive (the “Class Period”), of the important July 6, 2021 lead...
Jun 15, 2021 03:00 pm ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against ChemoCentryx, Inc. (CCXI)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming July 6, 2021 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired ChemoCentryx, Inc. (“ChemoCentryx” or...
Jun 15, 2021 11:30 am ET
DEADLINE ALERT for CCXI, SKLZ, PCT, ATER: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Jun 14, 2021 10:54 pm ET
SHAREHOLDER ALERT: CLAIMSFILER REMINDS ARRY, CCXI, PCT, WISH INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: ChemoCentryx, Inc. (CCXI)Class Period: 11/26/2019 - 5/6/2021Lead Plaintiff Motion Deadline: July 6,...
Jun 12, 2021 02:11 pm ET
Class Action Alert: Kessler Topaz Meltzer & Check, LLP Reminds CCXI Investors for Securities Fraud Class Action Lawsuit
The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors that a securities fraud class action lawsuit has been filed in the United States District Court for the Northern District of California against ChemoCentryx, Inc. (NASDAQ: CCXI)...
Jun 12, 2021 11:05 am ET
HAGENS BERMAN Alerts ChemoCentryx (CCXI) Investors to EXPANDED FRAUDULENT PERIOD in Securities Fraud Action: Investors with Losses Should Contact the Firm
Hagens Berman urges ChemoCentryx, Inc. (NASDAQ: CCXI) investors with significant losses to submit your losses now. A securities fraud class action is pending and certain investors may have valuable claims. Class Period: Nov. 26, 2019 – May 6,...
Jun 11, 2021 10:00 pm ET
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS ARRY, CCXI, PCT, WISH INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: ChemoCentryx, Inc. (CCXI)Class Period: 11/26/2019...
Jun 11, 2021 01:30 pm ET
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ChemoCentryx, Inc. and Encourages Investors With Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ChemoCentryx, Inc. (“ChemoCentryx” or “the Company”) (NASDAQ:
Jun 11, 2021 01:00 pm ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against ChemoCentryx, Inc. (CCXI)
LOS ANGELES, June 11, 2021 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming July 6, 2021 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired ChemoCentryx, Inc. ("ChemoCentryx" or the "Company") (NASDAQ: CCXI) common stock between November 26, 2019 and May 6, 2021, inclusive (the "Class Period").If you suffered a loss on your ChemoCentryx investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit y
Jun 11, 2021 11:35 am ET
Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against ChemoCentryx, Inc.
RADNOR, Pa., June 11, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP reminds ChemoCentryx, Inc. (NASDAQ:  CCXI) ("ChemoCentryx") investors that a securities fraud class action lawsuit has been filed on behalf of those who purchased or acquired ChemoCentryx common stock between November 26, 2019 and May 6, 2021, inclusive (the "Class Period").
Jun 11, 2021 08:30 am ET
Thinking about buying stock in Novan, Chemomab Therapeutics, Precigen, ChemoCentryx, or Senseonics?
NEW YORK, June 11, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NOVN, CMMB, PGEN, CCXI, and SENS.
Jun 11, 2021 04:00 am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ChemoCentryx, Inc. - CCXI
NEW YORK, June 11, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ChemoCentryx, Inc. ("ChemoCentryx" or the "Company") (NASDAQ: CCXI).   Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
Jun 10, 2021 05:30 pm ET
SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ChemoCentryx, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ChemoCentryx, Inc. (“ChemoCentryx” or “the Company”) (NASDAQ:
Jun 10, 2021 04:45 pm ET
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts ChemoCentryx (CCXI) Investors to EXPANDED FRAUDULENT PERIOD in Securities Fraud Action: Investors Should Secure Counsel
SAN FRANCISCO, June 10, 2021 /PRNewswire/ -- Hagens Berman urges ChemoCentryx, Inc. (NASDAQ: CCXI) investors with significant losses to submit your losses now.  A securities fraud class action is pending and certain investors may have valuable claims.
Jun 09, 2021 10:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Peloton and ChemoCentryx and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Peloton Interactive, Inc. (NASDAQ: PTON) and ChemoCentryx, Inc. (NASDAQ: CCXI)....
Jun 09, 2021 09:37 pm ET
SHAREHOLDER ALERT: CLAIMSFILER REMINDS ARRY, CCXI, PCT, WISH INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: ChemoCentryx, Inc. (CCXI)Class Period: 11/26/2019 - 5/6/2021Lead Plaintiff Motion Deadline: July 6,...
Jun 09, 2021 01:22 pm ET
SHAREHOLDER ALERT: Robbins LLP Reminds Investors that ChemoCentryx, Inc. (CCXI) is Being Sued for Misleading Shareholders
Shareholder rights law firm Robbins LLP reminds investors that a purchaser of ChemoCentryx, Inc. (NASDAQ: CCXI) filed a class action complaint against the Company and its officers and directors for alleged violations of the Securities Exchange Act of 1934 between November 26, 2019 and May 3, 2021. ChemoCentryx is a biopharmaceutical c
Jun 09, 2021 12:01 pm ET
Scott+Scott Attorneys at Law LLP Reminds Investors to Securities Class Action Against ChemoCentryx, Inc. (CCXI) and July 6 Deadline
ChemoCentryx is a biopharmaceutical company. ChemoCentryx's lead drug candidate is avacopan, which the Company describes as “a first-in-class, orally-administered small molecule that employs a novel, highly targeted mode of action in the treatment of ANCA-associated vasculitis and other complement-driven autoimmune and inflammatory diseases.” On July 9, 2020, ChemoCentryx announced that it had filed its New Drug Application (“NDA”) for avacopan, and on September 17, 2020, the Company announced that the U.S. Food & Drug Administration (“FDA”) had accepted the NDA for review.
Jun 09, 2021 11:45 am ET
DEADLINE ALERT for PINS, VWAGY, CCXI, and SKLZ: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the deadlines listed below to file a lead plaintiff motion....
Jun 09, 2021 11:30 am ET
ROSEN, A TOP RANKED LAW FIRM, Encourages ChemoCentryx, Inc. Investors to Secure Counsel Before Important July 6 Deadline in Securities Class Action with Expanded Class Period – CCXI
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of ChemoCentryx, Inc. (NASDAQ: CCXI) between November 26, 2019 and May 6, 2021, inclusive (the “Class Period”), of the important July 6, 2021 lead...
Jun 08, 2021 10:39 pm ET
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of ARRY, CCXI, PCT and WISH
The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of the following publicly traded companies. ChemoCentryx, Inc. (CCXI)Class Period: September 11, 2020 and May 5, 2021Lead Plaintiff Motion Deadline: July 6,...
Jun 08, 2021 05:27 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ChemoCentryx, Inc. - CCXI
Pomerantz LLP is investigating claims on behalf of investors of  ChemoCentryx, Inc. (“ChemoCentryx” or the “Company”) (NASDAQ: CCXI). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980....
Jun 08, 2021 05:10 pm ET
CCXI CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Reminds ChemoCentryx, Inc. Shareholders of Securities Fraud Class Action Lawsuit
The law firm of Kessler Topaz Meltzer & Check, LLP reminds ChemoCentryx, Inc. (NASDAQ: CCXI) (“ChemoCentryx”) investors that a securities fraud class action lawsuit has been filed in the United States District Court for the Northern District of...
Jun 08, 2021 12:30 pm ET
DEADLINE ALERT for CCXI, SKLZ, PCT, ATER: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Jun 08, 2021 08:30 am ET
ChemoCentryx Announces Abstract on Avacopan in ANCA-Associated Vasculitis Selected as One of the Ten Best Abstracts at the ERA-EDTA Congress
ChemoCentryx, Inc., (Nasdaq: CCXI), today announced presentations highlighting outcomes of the Company’s Phase III ADVOCATE trial and Phase II ACCOLADE and LUMINA-1 trials as part of the annual meeting of the ERA-EDTA (European Renal Association –...
Jun 07, 2021 10:57 pm ET
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS ARRY, CCXI, PCT, WISH INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: ChemoCentryx, Inc. (CCXI)Class Period: 11/26/2019...
Jun 07, 2021 03:01 pm ET
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages ChemoCentryx (CCXI) Investors with Losses to Contact its Attorneys, Securities Fraud Lawsuit Filed
Hagens Berman urges ChemoCentryx, Inc. (NASDAQ: CCXI) investors with significant losses to submit your losses now. A securities fraud class action is pending and certain investors may have valuable claims. Class Period: Nov. 26, 2019 – May 3,...
Jun 07, 2021 11:30 am ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against ChemoCentryx, Inc. (CCXI)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming July 6, 2021 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired ChemoCentryx, Inc. (“ChemoCentryx” or...
Jun 04, 2021 10:00 pm ET
SHAREHOLDER ALERT: CLAIMSFILER REMINDS ARRY, CCXI, PCT, WISH INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: ChemoCentryx, Inc. (CCXI)Class Period: 11/26/2019 - 5/3/2021Lead Plaintiff Motion Deadline: July 6,...
Jun 04, 2021 10:50 am ET
Kessler Topaz Meltzer & Check, LLP: Securities Fraud Class Action Lawsuit Filed Against ChemoCentryx, Inc.
The law firm of Kessler Topaz Meltzer & Check, LLP reminds ChemoCentryx, Inc. (NASDAQ: CCXI) (“ChemoCentryx”) investors that a securities fraud class action lawsuit has been filed in the United States District Court for the Northern District of...
Jun 03, 2021 03:00 pm ET
PINS, VWAGY & CCXI Shareholder Reminders: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Encourages Investors to Contact the Firm
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
Jun 03, 2021 10:45 am ET
DEADLINE ALERT for PINS, VWAGY, CCXI, and SKLZ: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the deadlines listed below to file a lead plaintiff motion....
Jun 02, 2021 11:27 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ChemoCentryx, Inc. - CCXI
Pomerantz LLP is investigating claims on behalf of investors of ChemoCentryx, Inc. (“ChemoCentryx” or the “Company”) (NASDAQ: CCXI).  Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980....
Jun 02, 2021 09:56 pm ET
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS ARRY, CCXI, PCT, WISH INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: ChemoCentryx, Inc. (CCXI)Class Period: 11/26/2019...
Jun 02, 2021 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Peloton and ChemoCentryx and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Peloton Interactive, Inc. (NASDAQ: PTON) and ChemoCentryx, Inc. (NASDAQ: CCXI)....
Jun 01, 2021 10:00 pm ET
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of ARRY, CCXI, PCT and WISH
The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of the following publicly traded companies. ChemoCentryx, Inc. (CCXI)Class Period: September 11, 2020 and May 5, 2021Lead Plaintiff Motion Deadline: July 6,...
Jun 01, 2021 08:03 pm ET
ChemoCentryx, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm
The Portnoy Law Firm advises investors that a class action lawsuit has been filed on behalf of ChemoCentryx, Inc. (NASDAQ: CCXI) investors that acquired shares between November 26, 2019 and May 3, 2021. Investors have until July 6, 2021 to seek an...
May 31, 2021 10:31 pm ET
SHAREHOLDER ALERT: CLAIMSFILER REMINDS ARRY, CCXI, PCT, WISH INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: ChemoCentryx, Inc. (CCXI)Class Period: 11/26/2019 - 5/3/2021Lead Plaintiff Motion Deadline: July 6,...
May 31, 2021 01:08 pm ET
CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Announces Class Action Lawsuit Has Been Filed Against ChemoCentryx, Inc.
The law firm of Kessler Topaz Meltzer & Check, LLP reminds ChemoCentryx, Inc. (NASDAQ: CCXI) (“ChemoCentryx”) investors that a securities fraud class action lawsuit has been filed in the United States District Court for the Northern District of...
May 31, 2021 09:15 am ET
HAGENS BERMAN Encourages ChemoCentryx (CCXI) Investors with Losses to Contact the Firm Now, Securities Fraud Lawsuit Pending
Hagens Berman urges ChemoCentryx, Inc. (NASDAQ: CCXI) investors with significant losses to submit your losses now. A securities fraud class action is pending and certain investors may have valuable claims. Class Period: Nov. 26, 2019 – May 3,...
May 30, 2021 03:30 pm ET
ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages ChemoCentryx, Inc. Investors with Losses to Secure Counsel Before Important Deadline – CCXI
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of ChemoCentryx, Inc. (NASDAQ: CCXI) between November 26, 2019 and May 3, 2021, inclusive (the “Class Period”), of the important July 6, 2021 lead plaintiff deadline.
May 28, 2021 10:00 pm ET
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS ARRY, CCXI, PCT, WISH INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: ChemoCentryx, Inc. (CCXI)Class Period: 11/26/2019...
May 28, 2021 01:00 pm ET
DEADLINE ALERT for CCXI, SKLZ, PCT, ATER: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
May 27, 2021 05:45 pm ET
ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED LAW FIRM, Encourages ChemoCentryx, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline – CCXI
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of ChemoCentryx, Inc. (NASDAQ: CCXI) between November 26, 2019 and May 3, 2021, inclusive (the “Class Period”), of the important July 6, 2021 lead plaintiff...
May 27, 2021 11:30 am ET
DEADLINE ALERT for PINS, VWAGY, CCXI, and SKLZ: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the deadlines listed below to file a lead plaintiff motion....
May 27, 2021 11:00 am ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against ChemoCentryx, Inc. (CCXI)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming July 6, 2021 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired ChemoCentryx, Inc. (“ChemoCentryx” or...
May 26, 2021 10:42 pm ET
SHAREHOLDER ALERT: CLAIMSFILER REMINDS ARRY, CCXI, PCT, WISH INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: ChemoCentryx, Inc. (CCXI)Class Period: 11/26/2019 - 5/3/2021Lead Plaintiff Motion Deadline: July 6,...
May 26, 2021 09:03 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ChemoCentryx, Inc. - CCXI
Pomerantz LLP is investigating claims on behalf of investors of  ChemoCentryx, Inc. (“ChemoCentryx” or the “Company”) (NASDAQ: CCXI). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980....
May 26, 2021 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Peloton and ChemoCentryx and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Peloton Interactive, Inc. (NASDAQ: PTON) and ChemoCentryx, Inc. (NASDAQ: CCXI)....
May 26, 2021 08:00 am ET
LAWSUIT FILED: Block & Leviton LLP Has Filed a Lawsuit Against ChemoCentryx, Inc. for Securities Fraud; Investors Who Lost Money Should Contact the Firm
Block & Leviton LLP (www.blockleviton.com), a national securities litigation firm, announces that has filed a class action lawsuit on behalf of shareholders against ChemoCentryx, Inc. (NASDAQ: CCXI) and certain of its executives for securities...
May 25, 2021 10:00 pm ET
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of ARRY, CCXI, PCT and WISH
The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of the following publicly traded companies. ChemoCentryx, Inc. (CCXI)Class Period: September 11, 2020 and May 5, 2021Lead Plaintiff Motion Deadline: July 6,...
May 25, 2021 12:26 pm ET
HAGENS BERMAN Alerts ChemoCentryx (CCXI) Investors to Securities Fraud Lawsuit, Encourages Investors with Losses to Contact the Firm Before Approaching Application Deadline
Hagens Berman urges ChemoCentryx, Inc. (NASDAQ: CCXI) investors with significant losses to submit your losses now. A securities fraud class action is pending and certain investors may have valuable claims. Class Period: Nov. 26, 2019 – May 3,...
May 25, 2021 10:00 am ET
PINS, VWAGY & CCXI Shareholder Reminders: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Encourages Investors to Contact the Firm
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
May 25, 2021 08:00 am ET
ChemoCentryx, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm
The Portnoy Law Firm advises investors that a class action lawsuit has been filed on behalf of ChemoCentryx, Inc. (NASDAQ: CCXI) investors that acquired shares between November 26, 2019 and May 3, 2021. Investors have until July 6, 2021 to seek an...
May 24, 2021 10:45 pm ET
ARRY, CCXI, PCT, WISH SHAREHOLDERS - ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Class Action lawsuits filed on behalf of Investors, Lead Plaintiff Deadlines Set
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: ChemoCentryx, Inc. (CCXI)Class Period: 11/26/2019...
May 23, 2021 03:10 pm ET
Kessler Topaz Meltzer & Check, LLP Reminds ChemoCentryx, Inc. Investors of Important Deadline in Securities Fraud Class Action Lawsuit
The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors that a securities fraud class action lawsuit has been filed in the United States District Court for the Northern District of California against ChemoCentryx, Inc. (NASDAQ: CCXI)...
May 21, 2021 10:00 pm ET
SHAREHOLDER ALERT: CLAIMSFILER REMINDS ARRY, CCXI, PCT, WISH INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: ChemoCentryx, Inc. (CCXI)Class Period: 11/26/2019 - 5/3/2021Lead Plaintiff Motion Deadline: July 6,...
May 21, 2021 11:15 am ET
DEADLINE ALERT for PINS, VWAGY, and CCXI: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the deadlines listed below to file a lead plaintiff motion....
May 20, 2021 10:04 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of ChemoCentryx, Inc. – CCXI
Pomerantz LLP is investigating claims on behalf of investors of ChemoCentryx, Inc. (“ChemoCentryx” or the “Company”) (NASDAQ: CCXI). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980....
May 20, 2021 12:15 pm ET
HAGENS BERMAN Advises ChemoCentryx (CCXI) Investors with Losses to Contact the Firm, Securities Fraud Class Action Filed
Hagens Berman urges ChemoCentryx, Inc. (NASDAQ: CCXI) investors with significant losses to submit your losses now. A securities fraud class action is pending and certain investors may have valuable claims. Class Period: Nov. 26, 2019 – May 3,...
May 20, 2021 08:00 am ET
LAWSUIT FILED: Block & Leviton LLP Has Filed a Lawsuit Against ChemoCentryx, Inc. for Securities Fraud; Investors Who Lost Money Should Contact the Firm
Block & Leviton LLP (www.blockleviton.com), a national securities litigation firm, announces that it has filed a class action lawsuit on behalf of shareholders against ChemoCentryx, Inc. (NASDAQ: CCXI) and certain of its executives for securities...
May 19, 2021 10:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Peloton, Repro Med, and ChemoCentryx and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Peloton Interactive, Inc. (NASDAQ: PTON), Repro Med Systems, Inc. d/b/a KORU...
May 19, 2021 10:00 pm ET
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS ARRY, CCXI, PCT, WISH INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: ChemoCentryx, Inc. (CCXI)Class Period:...
May 19, 2021 03:09 pm ET
Kessler Topaz Meltzer & Check, LLP: Securities Fraud Class Action Lawsuit Filed Against ChemoCentryx, Inc.
The law firm of Kessler Topaz Meltzer & Check, LLP reminds ChemoCentryx, Inc. (NASDAQ: CCXI) (“ChemoCentryx”) investors that a securities fraud class action lawsuit has been filed in the United States District Court for the Northern District of...
May 18, 2021 10:51 pm ET
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of ARRY, CCXI and PCT
The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of the following publicly traded companies. ChemoCentryx, Inc. (CCXI)Class Period: September 11, 2020 and May 5, 2021Lead Plaintiff Motion Deadline: July 6,...
May 18, 2021 07:08 pm ET
CCXI INVESTOR NEWS: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages ChemoCentryx, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline – CCXI
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of ChemoCentryx, Inc. (NASDAQ: CCXI) between November 26, 2019 and May 3, 2021, inclusive (the “Class Period”), of the important July 6, 2021 lead plaintiff deadline.
May 17, 2021 10:00 pm ET
SHAREHOLDER ALERT: CLAIMSFILER REMINDS CCXI, PCT, PTON INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: Peloton Interactive, Inc. (PTON)Class Period: 9/11/2020 - 5/5/2021Lead Plaintiff Motion Deadline: June...
May 17, 2021 01:00 pm ET
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against ChemoCentryx, Inc. (CCXI)
Law Offices of Howard G. Smith reminds investors of the upcoming July 6, 2021 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased ChemoCentryx, Inc. (“ChemoCentryx” or the “Company”) (NASDAQ: CCXI) common stock between November 26, 2019 and May 3, 2021, inclusive (the “Class Period”).
May 17, 2021 12:19 pm ET
Scott+Scott Attorneys at Law LLP Alerts Investors to Securities Class Action Against ChemoCentryx, Inc. (CCXI) and July 6 Deadline
Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international shareholder and consumer rights litigation firm, announces the filing of a class action lawsuit against ChemoCentryx, Inc. (“ChemoCentryx” or the “Company”) (NASDAQ: CCXI) and certain of its officers, alleging violations of federal securitie
May 15, 2021 03:25 pm ET
CCXI INVESTORS ACT NOW: Contact HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, to Recover Losses Due to Alleged Securities Fraud
Hagens Berman urges ChemoCentryx, Inc. (NASDAQ: CCXI) investors with significant losses to submit your losses now. A securities fraud class action is pending and certain investors may have valuable claims. Class Period: Nov. 26, 2019 – May 3,...
May 14, 2021 10:50 pm ET
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS CCXI, PCT, PTON INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: Peloton Interactive, Inc. (PTON)Class Period:...
May 14, 2021 04:15 pm ET
ROSEN, A LEADING LAW FIRM, Encourages ChemoCentryx, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline – CCXI
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of ChemoCentryx, Inc. (NASDAQ: CCXI) between November 26, 2019 and May 3, 2021, inclusive (the “Class...
May 14, 2021 01:46 pm ET
Investor Alert: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against ChemoCentryx, Inc. – CCXI
The law firm of Kessler Topaz Meltzer & Check, LLP reminds ChemoCentryx, Inc. (NASDAQ: CCXI) (“ChemoCentryx”) investors that a securities fraud class action lawsuit has been filed in the United States District Court for the Northern District of...
May 14, 2021 12:00 pm ET
DEADLINE ALERT for PINS, VWAGY, and CCXI: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the deadlines listed below to file a lead plaintiff motion....
May 13, 2021 10:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Peloton, Repro Med, and ChemoCentryx and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Peloton Interactive, Inc. (NASDAQ: PTON), Repro Med Systems, Inc. d/b/a KORU...
May 13, 2021 11:00 am ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against ChemoCentryx, Inc. (CCXI)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming July 6, 2021 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired ChemoCentryx, Inc. (“ChemoCentryx” or the “Company”) (NASDAQ:

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.